Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study

Journal of the American Society of Hypertension

Volumn 6, Issue 3, 2012, Pages 193-200

  Esquitin, Ricardo ^a   Razzouk, Louai ^b   Peterson, Gail E ^c   Wright Jr , Jackson T ^d   Phillips, Robert A ^e   De Backer, Tine L ^f   Baran, David A ^g   Kendrick, Cynthia ^h   Greene, Tom ⁱ   Reiffel, James ^j,k   Muntner, Paul ^l   Farkouh, Michael E ^m  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^j NewYork Presbyterian Hospital   (United States)

^k CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

African American; echocardiography; electrocardiography; Hypertension; kidney disease; left ventricular hypertrophy

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; COHORT ANALYSIS; CORE LABORATORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADRENERGIC BETA-ANTAGONISTS; AFRICAN AMERICANS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENAL; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; UNITED STATES;

EID: 84859965704     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2012.01.004     Document Type: Article

References (28)

1. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 1998;31:383-90. (Pubitemid 28153459)
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003;289:2560-71.
3. Pewsner D, Jüni P, Egger M, Battaglia M, Sundström J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ 2007;335:711.
4. Lee DK, Marantz PR, Devereux RB, Kligfield P, Alderman MH. Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence. JAMA 1992;267:3294-9.
5. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986;7:639-50. (Pubitemid 16164393)
6. Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993;87:476-86. (Pubitemid 23040918)
7. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, et al. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol 1994;24:1492-8. (Pubitemid 24344245)
8. Arnett DK, Rautaharju P, Sutherland S, Usher B, Keil J. Validity of electrocardiographic estimates of left ventricular hypertrophy and mass in African Americans (The Charleston Heart Study). Am J Cardiol 1997;79:1289-92. (Pubitemid 27255187)
9. Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F, et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension 2005;46:124-9. (Pubitemid 40946502)
10. Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, et al. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension 2004;43:1182-8. (Pubitemid 38691738)
11. Appel LJ, Middleton J, Miller ER, Lipkowitz M, Norris K, Agodoa LY, et al. The rationale and design of the AASK cohort study. J Am Soc Nephrol 2003;14(7 Suppl 2):S166-72. (Pubitemid 36750513)
12. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83. (Pubitemid 9091990)
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
15. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992;20:1251-60.
16. Zhou X, Obuchowski N, McClish D. Statistical methods in diagnostic medicine. New York: Wiley; 2002.
17. Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, et al. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint. Am J Hypertens 2002;15:663-71. (Pubitemid 34804270)
18. Peterson GE, de Backer T, Gabriel A, Ilic V, Vagaonescu T, Appel LJ, et al African American Study of Kidney Disease Investigators. Prevalence and correlates of left ventricular hypertrophy in the African American Study of Kidney Disease Cohort Study. Hypertension 2007;50:1033-9. (Pubitemid 350172924)
19. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990;81:815-20. (Pubitemid 20090377)
20. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity. J Am Coll Cardiol 1996;27:124-31. (Pubitemid 26018926)
21. Chinitz J, Cooper J, Verdino R. Electrocardiogram voltage discordance: interpretation of low QRS voltage only in the limb leads. J Electrocardiol 2008;41:281-6.
22. Carroll JD, Gaasch WH, McAdam KP. Amyloid cardiomyopathy: characterization by a distinctive voltage/-mass relation. Am J Cardiol 1982;49:9-13. (Pubitemid 12003501)
23. Fox KM, Tomlinson IW, Meek DR, Portal RW, Aber CP. Low voltage electrocardiogram after acute myocardial infarction. Br Heart J 1975;37:748-51.
24. Surawicz B, Knilans TK, Chou T-C. Chou's electrocardiography in clinical practice. Philadelphia, PA: W.B. Saunders Company; 2001. p. 709.
25. Rodman DM, Lowenstein SR, Rodman T. The electrocardiogram in chronic obstructive pulmonary disease. J Emerg Med 1990;8:607-15. (Pubitemid 20327456)
26. Bruch C, Schmermund A, Dagres N, Bartel T, Caspari G, Sack S, et al. Changes in QRS voltage in cardiac tamponade and pericardial effusion: reversibility after pericardiocentesis and after anti-inflammatory drug treatment. J Am Coll Cardiol 2001;38:219-26. (Pubitemid 32613854)
27. Alpert MA, Terry BE, Cohen MV, Fan TM, Painter JA, Massey CV. The electrocardiogram in morbid obesity. Am J Cardiol 2000;85:908-10. A10.
28. Madias JE, Bazaz R, Agarwal H, Win M, Medepalli L. Anasarca-mediated attenuation of the amplitude of electrocardiogram complexes: a description of a heretofore unrecognized phenomenon. J Am Coll Cardiol 2001;38:756-64. (Pubitemid 32835748)